---
title: "Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/271661710.md"
datetime: "2026-01-06T14:02:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271661710.md)
  - [en](https://longbridge.com/en/news/271661710.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271661710.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/271661710.md) | [繁體中文](https://longbridge.com/zh-HK/news/271661710.md)


# Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics

Day One Biopharmaceuticals has completed its acquisition of Mersana Therapeutics, expanding its pipeline with the addition of emiltatug ledadotin (Emi-Le), a clinical-stage antibody drug conjugate targeting the rare cancer adenoid cystic carcinoma (ACC). The transaction includes a payment of $25 per Mersana share in cash, plus a non-tradable contingent value right (CVR) per share, offering potential milestone payments of up to $30.25 per CVR. This move strengthens Day One’s focus on rare cancers and adult oncology, adding a second novel ADC to its clinical pipeline and building on the momentum of its marketed therapies. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Day One Biopharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9620634-en) on January 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [Day One Biopharmaceuticals (DAWN.US)](https://longbridge.com/zh-CN/quote/DAWN.US.md)

## 相关资讯与研究

- [Algert Global LLC Buys 411,000 Shares of Day One Biopharmaceuticals, Inc. $DAWN](https://longbridge.com/zh-CN/news/279382687.md)
- [Day One (DAWN) soars 100% on $2.5-billion merger](https://longbridge.com/zh-CN/news/278240035.md)
- [Servier All Cash Deal Reframes Day One Biopharmaceuticals Valuation Story](https://longbridge.com/zh-CN/news/278806564.md)
- [DayOne partners Cortical Labs to develop Singapore’s first biological data center](https://longbridge.com/zh-CN/news/278504184.md)
- [Day One Biopharmaceuticals, Inc. $DAWN Shares Sold by NEOS Investment Management LLC](https://longbridge.com/zh-CN/news/276532690.md)